Literature DB >> 21623747

Sun exposure rapidly reduces plasmacytoid dendritic cells and inflammatory dermal dendritic cells in psoriatic skin.

I Heier1, E Søyland, A-L Krogstad, C Rodríguez-Gallego, M S Nenseter, F L Jahnsen.   

Abstract

BACKGROUND: Interferon (IFN)-α-producing plasmacytoid dendritic cells (pDCs), inflammatory CD11c+CD1c- myeloid dendritic cells (mDCs) and macrophages have been found to contribute to the pathogenesis of psoriasis. Heliotherapy is a well-established treatment modality of this disease, although the details of how the effects are mediated are unknown.
OBJECTIVES: To test the hypothesis that exposure to natural sun affects pathogenic DC subsets in lesional skin.
METHODS: Skin biopsies were obtained from lesional and nonlesional skin in 10 patients with moderate to severe psoriasis subjected to controlled sun exposure on Gran Canaria. Biopsies were obtained at baseline, day 2 and day 16 and examined by immunohistochemistry.
RESULTS: Sixteen days of heliotherapy had excellent clinical effect on patients with psoriasis, with significant reductions in Psoriasis Area and Severity Index (PASI) scores. In lesional skin pDC numbers and expression of MxA, a surrogate marker for IFN-α, were rapidly reduced. Inflammatory CD11c+CD1c- mDCs were significantly reduced whereas resident dermal CD11c+CD1c+ mDCs were unaffected. Expression levels of the maturation marker DC-LAMP (CD208) on mDCs were significantly reduced after sun exposure, as were the numbers of lesional dermal macrophages. A decrease of dermal DC subsets and macrophages was already observed after 1 day of sun exposure. An additional finding was that DC-SIGN (CD209) is primarily expressed on CD163+ macrophages and not DCs.
CONCLUSIONS: The clinical improvement in psoriasis following sun exposure is associated with rapid changes in dermal DC populations and macrophages in lesional skin, preceding the clinical effect. These findings support the concept that these DC subsets are involved in the pathogenesis of psoriasis and suggest that sun-induced clinical benefit may partly be explained by its effect on dermal DCs.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623747     DOI: 10.1111/j.1365-2133.2011.10430.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

1.  Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease.

Authors:  Tea Skaaby; Lise Lotte Nystrup Husemoen; Betina Heinsbæk Thuesen; Allan Linneberg
Journal:  Endocrine       Date:  2015-02-11       Impact factor: 3.633

2.  H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease.

Authors:  P Ruscitti; P Cipriani; F Ciccia; P Di Benedetto; V Liakouli; O Berardicurti; F Carubbi; G Guggino; S Di Bartolomeo; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2016-07-28       Impact factor: 4.330

Review 3.  Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Literature Review and Discussion of Health Implications.

Authors:  Patrick J McCullough; William P McCullough; Douglas Lehrer; Jeffrey B Travers; Steven J Repas
Journal:  Nutrients       Date:  2021-04-29       Impact factor: 5.717

Review 4.  Human dendritic cell functional specialization in steady-state and inflammation.

Authors:  Arjan Boltjes; Femke van Wijk
Journal:  Front Immunol       Date:  2014-04-01       Impact factor: 7.561

Review 5.  Recent advances in understanding psoriasis.

Authors:  Franziska C Eberle; Jürgen Brück; Julia Holstein; Kiyoshi Hirahara; Kamran Ghoreschi
Journal:  F1000Res       Date:  2016-04-28

6.  Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study.

Authors:  Sushmita Das; Rakesh Mandal; Vidya Nand Rabidas; Neena Verma; Krishna Pandey; Ashok Kumar Ghosh; Sreekant Kesari; Ashish Kumar; Bidyut Purkait; Chandra Sekhar Lal; Pradeep Das
Journal:  PLoS Negl Trop Dis       Date:  2016-10-24

Review 7.  Plasmacytoid dendritic cells in dermatology.

Authors:  Natasha Favoretto Dias de Oliveira; Claudia Giuli Santi; Celina Wakisaka Maruta; Valeria Aoki
Journal:  An Bras Dermatol       Date:  2020-11-21       Impact factor: 1.896

8.  Zdhhc2 Is Essential for Plasmacytoid Dendritic Cells Mediated Inflammatory Response in Psoriasis.

Authors:  Binhui Zhou; Wenyi Yang; Wushan Li; Le He; Liaoxun Lu; Lichen Zhang; Zhuangzhuang Liu; Ying Wang; Tianzhu Chao; Rong Huang; Yanrong Gu; Tingting Jia; Qiaoli Liu; Shuanghua Tian; Philippe Pierre; Takahiro Maeda; Yinming Liang; Eryan Kong
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

9.  Climatotherapy at the Dead Sea for psoriasis is a highly effective anti-inflammatory treatment in the short term: An immunohistochemical study.

Authors:  Thomas Emmanuel; Annita Petersen; Hannah Inez Houborg; Anders Benjamin Rønsholdt; Dorte Lybaek; Torben Steiniche; Anne Bregnhøj; Lars Iversen; Claus Johansen
Journal:  Exp Dermatol       Date:  2022-02-27       Impact factor: 4.511

10.  The role of plasmacytoid dendritic cells and interferon-alpha in the immunopathogenesis of psoriasis.

Authors:  Rafael Denadai
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.